These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 24908971)

  • 21. [Effectiveness of adjuvant chemotherapy in patient with early stages of non-small cell lung cancer depending on proliferation index of tumor].
    Kolesnik AP
    Lik Sprava; 2014; (1-2):110-7. PubMed ID: 24908971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N; Shepherd FA; Winton T; Graham B; Johnson D; Livingston R; Rigas J; Whitehead M; Ding K; Seymour L
    Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and targeted therapies for early-stage lung cancer.
    Byron E; Pinder-Schenck M
    Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy after pulmonary resection for lung cancer.
    Mascaux C; Shepherd FA
    Thorac Surg Clin; 2013 Aug; 23(3):401-10. PubMed ID: 23931022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.
    Ikeda N; Nagase S; Ohira T
    Ann Thorac Cardiovasc Surg; 2009 Jun; 15(3):144-9. PubMed ID: 19597387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.
    Betticher DC
    Lung Cancer; 2005 Dec; 50 Suppl 2():S9-16. PubMed ID: 16557669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative chemotherapy for non-small-cell lung cancer.
    Holmes EC
    Chest; 1993 Jan; 103(1 Suppl):30S-34S. PubMed ID: 8380131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.
    Lin TL; Brahmer JR
    Curr Oncol Rep; 2004 Jul; 6(4):251-8. PubMed ID: 15161575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer.
    Pisters KM
    Semin Radiat Oncol; 2000 Oct; 10(4):274-9. PubMed ID: 11040327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy after complete resection for early stage NSCLC.
    Scagliotti G; Novello S
    Lung Cancer; 2003 Dec; 42 Suppl 1():S47-51. PubMed ID: 14611914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy in older adults with non-small cell lung cancer.
    Gajra A
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors].
    Zirlik S; Lampert S; Hahn EG; Wiest GH; Brückl WM
    Pneumologie; 2007 Nov; 61(11):731-8. PubMed ID: 17948172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review.
    Chen S; Flower A; Ritchie A; Liu J; Molassiotis A; Yu H; Lewith G
    Lung Cancer; 2010 May; 68(2):137-45. PubMed ID: 20015572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.
    Bonomi M; Pilotto S; Milella M; Massari F; Cingarlini S; Brunelli M; Chilosi M; Tortora G; Bria E
    J Exp Clin Cancer Res; 2011 Dec; 30(1):115. PubMed ID: 22206620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy for non-small cell lung cancer.
    Crane EJ; Simon G
    Curr Treat Options Oncol; 2006 Jan; 7(1):51-8. PubMed ID: 16343368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of adjuvant chemotherapy in NSCLC.
    Scagliotti GV; Novello S
    Ann Oncol; 2006 May; 17 Suppl 5():v62-3. PubMed ID: 16807465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.